Financials

  • Market Capitalization 261.37 M
  • Employee 88
  • Founded 2016
  • CEO N/A
  • Website www.bridgebio.com
  • Headquarter Delaware, United States
  • FIGI BBG01L3GYF02
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.91
Relación precio/flujo de caja
34.38

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3331
RCKT
Rocket Pharmaceuticals, Inc. - Common Stock
2.48 USD-3.13%-4.98%-24.62%-36.73%272.24 M USD
3356
LRMR
Larimar Therapeutics, Inc. - Common Stock
2.53 USD-5.24%-12.15%-34.11%-39.33%262.82 M USD
3361
GLSI
Greenwich LifeSciences, Inc. - Common stock
17.77 USD+7.50%+4.65%+17.29%+74.22%260.83 M USD
3362
IPSC
Century Therapeutics, Inc. - Common Stock
1.44 USD-2.04%-2.70%-26.53%+161.82%260.75 M USD